|
PARP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.101900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.798200E-02 |
| Normal-vs-Stage2 |
1.201530E-02 |
| Normal-vs-Stage3 |
2.449000E-01 |
| Normal-vs-Stage4 |
1.897760E-01 |
| Stage1-vs-Stage2 |
3.483600E-01 |
| Stage1-vs-Stage3 |
5.239800E-01 |
| Stage1-vs-Stage4 |
9.168600E-01 |
| Stage2-vs-Stage3 |
2.466200E-01 |
| Stage2-vs-Stage4 |
7.517200E-01 |
| Stage3-vs-Stage4 |
6.605800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.685500E-02 |
| Normal-vs-AfricanAmerican |
4.469800E-02 |
| Normal-vs-Asian |
3.746600E-01 |
| Caucasian-vs-AfricanAmerican |
7.451000E-01 |
| Caucasian-vs-Asian |
9.561000E-01 |
| AfricanAmerican-vs-Asian |
8.502600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.102000E-02 |
| Normal-vs-Female |
2.080000E-01 |
| Male-vs-Female |
3.951000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.590340E-02 |
| Normal-vs-Extreme_Weight |
4.130000E-02 |
| Normal-vs-Obese |
5.126600E-01 |
| Normal-vs-Extreme_Obese |
3.970000E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.119000E-01 |
| Normal_Weight-vs-Obese |
6.959800E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.460600E-01 |
| Extreme_Weight-vs-Obese |
1.164580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.649200E-01 |
| Obese-vs-Extreme_Obese |
1.537230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.441400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.001200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.179700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.128110E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.161400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.965390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.050200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.944300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.178970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.743000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.189200E-01 |
| Normal-VS-Type2 PRCC |
4.244500E-03 |
| Normal-VS-KIRP CIMP |
4.621200E-01 |
| Normal-VS-Unclassified PRCC |
1.038360E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.786460E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.682200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.559600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.087000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.892800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.472000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.373900E-04 |
| Normal-vs-N1 |
8.733000E-01 |
| Normal-vs-N2 |
3.401200E-04 |
| N0-vs-N1 |
2.371900E-02 |
| N0-vs-N2 |
7.584000E-03 |
| N1-vs-N2 |
1.410090E-02 |
|
|
